Literature DB >> 7073351

Ten years portal hypertensive surgery at Emory. Results and new perspectives.

W D Warren, W J Millikan, J M Henderson, L Wright, M Kutner, R B Smith, J T Fulenwider, A A Salam, J T Galambos.   

Abstract

Five hundred four Shunt procedures have been done at Emory University Hospitals between 1971 and 1981 to decompress bleeding esophageal varices. This paper reviews how far the experiences of a prospective randomized study (55 patients) of distal splenorenal shunts against total shunts is supported by the nonrandomized experience (449 patients), and outlines our current methods of management dictated by this experience. The overall operative mortality for 348 selective shunts is 4.1% and for 156 nonselective shunts, 14.1%. The five-year survival following Selective shunt is 59%, and following nonselective shunt is 49%: more than half the selective shunt patients are alive, in contrast to the median survival of 44.5 months for patients having nonselective shunts. Following Selective shunt, the survival in nonalcoholic patients is significantly better than the median survival of alcoholic patients of 57 months. Encephalopathy, reported at three years after surgery in the randomized patients was significantly (p < 0.001) lower after selective shunt (12%) compared to nonselective shunt (52%): in the same population at seven years, all patients with patent nonselective shunts have clinical or subclinical encephalopathy, but only 30% of the selective shunt patients have subclinical encephalopathy. Shunt patency, immediately after surgery, is 93% following selective shunt, with only two documented late thromboses: nine of nine patients, at a mean of seven years, retain patency in the randomized study. Shunt occlusion increases with time after interposition nonselective shunts: seven of 13 are occluded at a mean follow-up of seven years in the randomized study. Portal venous perfusion is retained in 93% of patients seven to ten days after selective shunt, but in no patient with a patent nonselective shunt. Late portal perfusion is maintained in nine of the eleven patients in the randomized group studied at a mean of seven years after selective shunt. Restoration of portal perfusion has led to clearing of encephalopathy and improvement in hepatic function in six patients. The following conclusions are made: (1) selective shunts can be done with low operative mortality, and long-term patency with excellent control of bleeding; (2) hepatic portal venous perfusion has been maintained after selective shunt for ten years, and this is vital for preventing encephalopathy and maintaining hepatic function; (3) long-term survival after selective shunt is better than any reported series for nonselective shunt; and (4) selective shunts are the operative procedure of choice for variceal decompression and nonselective shunts should rarely be performed for elective decompression.

Entities:  

Mesh:

Year:  1982        PMID: 7073351      PMCID: PMC1352553          DOI: 10.1097/00000658-198205000-00002

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  39 in total

1.  Prospective comparative clinical trial with distal splenorenal and mesocaval shunts.

Authors:  F A Reichle; W F Fahmy; M Golsorkhi
Journal:  Am J Surg       Date:  1979-01       Impact factor: 2.565

2.  Portasystemic shunting procedures for portal hypertension. Twenty-six year experience in adults with cirrhosis of the liver.

Authors:  A B Voorhees; J B Price; R C Britton
Journal:  Am J Surg       Date:  1970-05       Impact factor: 2.565

3.  Selection of operation in patients with bleeding esophageal varices.

Authors:  B Langer; S C Patel; R M Stone; R F Colapinto; M J Phillips; M M Fisher
Journal:  Can Med Assoc J       Date:  1978-02-18       Impact factor: 8.262

4.  Angiography in portal hypertension: clinical significance in surgery.

Authors:  B M Nordlinger; D F Nordlinger; J T Fulenwider; W J Millikan; P J Sones; M Kutner; R Steele; R Bain; W D Warren
Journal:  Am J Surg       Date:  1980-01       Impact factor: 2.565

5.  The distal splenorenal shunt: an enigma.

Authors:  D C Nabseth
Journal:  Am J Surg       Date:  1981-05       Impact factor: 2.565

6.  Selective and total shunts in the treatment of bleeding varices. A randomized controlled trial.

Authors:  J T Galambos; W D Warren; D Rudman; R B Smith; A A Salam
Journal:  N Engl J Med       Date:  1976-11-11       Impact factor: 91.245

7.  Hyperalimentation in alcoholic hepatitis.

Authors:  J T Galambos; T Hersh; J T Fulenwider; J D Ansley; D Rudman
Journal:  Am J Gastroenterol       Date:  1979-11       Impact factor: 10.864

8.  Comparison of distal and proximal splenorenal shunts: a randomized prospective trial.

Authors:  J E Fischer; R H Bower; S Atamian; R Welling
Journal:  Ann Surg       Date:  1981-10       Impact factor: 12.969

9.  Dacron interposition shunts for portal hypertension. An analysis of morbidity correlates.

Authors:  R B Smith; W D Warren; A A Salam; W J Millikan; J D Ansley; J T Galambos; M Kutner; R P Bain
Journal:  Ann Surg       Date:  1980-07       Impact factor: 12.969

10.  Acute bleeding varices: a five-year prospective evaluation of tamponade and sclerotherapy.

Authors:  J Terblanche; H I Yakoob; P C Bornman; G V Stiegmann; R Bane; M Jonker; J Wright; R Kirsch
Journal:  Ann Surg       Date:  1981-10       Impact factor: 12.969

View more
  53 in total

1.  Bleeding from peristomal varices: a complication of portal hypertension.

Authors:  Faraan Khan; Sheida Vessal; Richard Gordon-Williams
Journal:  BMJ Case Rep       Date:  2011-09-26

Review 2.  Portal hypertension--25 years of progress.

Authors:  B R MacDougall; D Westaby; L A Blendis
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

3.  TIPS for portal decompression to allow palliative treatment of adenocarcinoma of the esophagus.

Authors:  G Moulin; P Champsaur; J M Bartoli; C Chagnaud; H Rousseau; D Monges
Journal:  Cardiovasc Intervent Radiol       Date:  1995 May-Jun       Impact factor: 2.740

4.  Transjugular portosystemic shunt for treatment of bleeding stomal varices.

Authors:  P A Johnson; J Laurin
Journal:  Dig Dis Sci       Date:  1997-02       Impact factor: 3.199

5.  The Emory prospective randomized trial: selective versus nonselective shunt to control variceal bleeding. Ten year follow-up.

Authors:  W J Millikan; W D Warren; J M Henderson; R B Smith; A A Salam; J T Galambos; M H Kutner; J H Keen
Journal:  Ann Surg       Date:  1985-06       Impact factor: 12.969

6.  Distal splenorenal shunt for management of variceal bleeding in patients with schistosomal hepatic fibrosis.

Authors:  F A Ezzat; K M Abu-Elmagd; I Y Aly; M A Aly; O M Fathy; M H el-Barbary; O O Bahgat; A A Salam; M H Kutner
Journal:  Ann Surg       Date:  1986-11       Impact factor: 12.969

7.  Natural history of a randomized trial comparing distal spleno-renal shunt with endoscopic sclerotherapy in the prevention of variceal rebleeding: a lesson from the past.

Authors:  Roberto Santambrogio; Enrico Opocher; Mara Costa; Savino Bruno; Andrea Pisani Ceretti; Gian Paolo Spina
Journal:  World J Gastroenterol       Date:  2006-10-21       Impact factor: 5.742

Review 8.  Surgical management of portal hypertension.

Authors:  J C Collins; I J Sarfeh
Journal:  West J Med       Date:  1995-06

9.  Factors affecting immediate and long-term survival after emergent and elective splanchnic-systemic shunts.

Authors:  J G Chandler; C H Van Meter; D L Kaiser; S E Mills
Journal:  Ann Surg       Date:  1985-04       Impact factor: 12.969

10.  Liver transplantation in patients with previous portasystemic shunt.

Authors:  V Mazzaferro; S Todo; A G Tzakis; A C Stieber; L Makowka; T E Starzl
Journal:  Am J Surg       Date:  1990-07       Impact factor: 2.565

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.